Abstract --M;ycotoxin metabolism is discussed in relation to ~xification, (2) metabolic activation and mode of action, and (3) the public health problem arising from the possible accumulation of toxic residues in the tissues of farm animals conSUllling toxinconteminated feedso The aflatoxins, sterigmatocystin, ochratoxins A end B, the trichothecenes, and zearelenone are considered as far as our available knowledge permitso M;,rcotoxin metabolism ~ not only take place in the liver; the skin and gastro-intestinal tract ~ be alternative siteso INTRODUCTION
INTRODUCTION
In the paper for one of the poster sessions at this Symposium I have already referred to our limi ted knowledge of m:ycotoxin metaboliem (Ref o 1) o Even in the case of aflatoxin the relationship between metabolism and toxicity is still being explored end, by comparison, very li ttle is known of this aspect of the metabolism of the erowing number of m:ycotoxins that have now been implicated in clinical or experimental enimal diseaseo Despite the somewhat limited information available in some cases, I shall briefly consider the metabolism of the aflatoxins, sterigmatocystin, ochratoxins A and B, and the Fusarium toxins.with regard to their mode of action and their potential for accumulating as toxic residues in enimal tissueso Befors doing this however, it ~ be useful to define a few terms that I shall be usingo "Detoxification" will be tak:en to meen the biotrensformation of a toxin, usually by the microsomal mixed tunction oxidases of the liver, to a metabolite that is either non-toxic when ingested b7 a second enimal of the same or different species, or a metabolite that results from the conjugation of the toxin with cysteine, glutathione, or glucuronic, taurocholic or sulphuric acids in a further microsomal reaction to form mors polar compounds that are rapidly eliminated from the body by excretion into the urine or bile for exam:pleo A m:ycotoxin will be said to have the potential for accumulating "toxic residues" in body tissues when its metabolism in vitro or better still in vivo is known to be slow or, alternatively, when a sisnJ.ficent pathway of metabolism results in the formation of one or mors metabol! tes wi th no appreciable loss in toxici ty and when such a product is slowly eliminated from the bodyo This potential problem is greatest when the enimal in question is destined for use as human foodo ~tabolic Activation" differs from the above in that it involves biotrensformation of the m:ycotoxin in question to at least one metabolite which, unlike the toxic metabolites just mentioned, is mors toxic then the parent toxin and also plays a key role in the mechanism of toxic action in the appropriate target orgeno Clearly the precise outcome of these possible metabolic processes or biotrensformations will depend upon their relative importence in a given animal species but, by definition, none of the toxins in question are detoxified so well that enimals are entirely unaffected by toxin ingestiono In certain enimal species however these "detoxifYing" pathways appear to be better developed then in otherso Metabolie activation, on the other hand, is a property not coDDOn to all m:ycotoxins and appears to be reserved for the most potent oneso Perhaps we can regard this as similar to the type of reaction which, in an entirely different context, Sir Rudolph Peters referred to as "lethal syrithesis" o These generalised aspects of m:ycotoxin metabolism are SUJIIIII81'ised in Figo 1 end the metabolism of some individual m:ycotoxins will now be considered in this genersl format but not in great detail so as to provide an overview of as many toxins as possibleo m5 and 01 and apart from 01 and m5 the G series of aflatoxins ~ be metabolised througb the same pathw~s. GS denotes glutathione.
As summarized in Fig. 2 aflatoxin B 1 metaboliBm may be considered under all three of the above headings.
Detoxification. Aflatoxin B1 may be transfomed in the liver into three hydroxylated metabolites (arlatoxicol, aflatoxin Q1 and aflatoxin P1) that are at least theoretically capable of conjugation to polar compounds suitable for rapid elimination from the body. To this extent these reactions involve detoxification and when tested in various in vivo systems for acute toxicity they are all appreciably lese toxic than the parent toxin (see review, Ref.
2).
Aflatoxicol occupies a special position in that it is not fomed in a microsomal mixed function oxidase reaction but by an NADP-linked dehydrogenase of the cytosol which also has 17-ketosteroid dehydrogenase activity. Furthermore this reaction is reversible to a greater or lesser extent and it has been proposed (Ref. 3 and 4) that this reversible reaction constitutes a "metabolic reservoir" of aflatoxin. Recently this suggestion has been developed further by Hsieh (Ref. 5) to provide a good correlation between this type of metaboliBm and an animal's susceptibility to aflatoxin poisoning.
It will also be noted from Fig. 2 that the same enzymic reduction of the cyclopentenone carbonyl group occurs in the case of aflatoxin Q1 and probably this reaction is reversible.
Taxie residues. Aflatoxin is metabolised more rapidly by some animal species than others (Ref. The first proposal made in our laboratory (Ref. 9 and 10) was that, as the metabolic conversion of aflatoxin B1 to its hemiacetal, B2a appeared to be characteristic of livers of animal speciee susceptible to acute aflatoxin poieoning, it was in this fom that it inte~ acted with vital functions of the liver cell leading to hepatocellular necrosis. At physiological and alkaline pH valuee it was known that aflatoxin hemiacetal rearranges to dialdehydic phenolate resonance hybrid ions (Ref. 11) andin this fom it reacted with aminoacids, peptides and proteins to fom Schiff bases (see Fig. 3 ). An important distinction was made between metabolic formation and toxicity of this product within the hepatocyte and the known lack of oral toxicity of aflatoxin hemiacetal in vivo. The latter we felt, could be explained by its avid protein binding capacity and thus its Sequestration by the deciduous cells of the gastrointestinal tract. In this way it would effectively escape significant absorption. Thus, intra-hepatocellular formation of the hemiacetal was the central feature of this hypothesis but equal emphasis has always been placed on the fact that this biotransformation is best developed in the nomal livers of animal epecies with a high susceptibility to acute aflatoxin poisoning.
The second proposal originated by Gar.ner and his colleagues (Ref. 12 and 13) was that livers of most, if not all, animal species are capable of converting aflatoxin B1 to an unidentified toxic metabolite which could be assayed in a bacterial mutagenicity test. It was suggested that this metabolic product was the 2,3-oxide, that it had a transient existence and that it alkylated bacterial DNA. So far there is no direct evidence for the 2,3-oxide but it has been shown (Ref. 14) that when aflatoxin B1 was incubated in vitro with liver microsomee and RNA or DNA, a nucleic acid adduct was fomed which, on mild hydrolysis, yielded the 2,3-dihydrodiol of aflatoxin, indirectly suggesting prior formation of the 2, 3-oxide. Further studies by Swenson and his colleagues (Ref. 15) have shown that synthetic aflatoxin 2,3-dichloride can mimic the biological effects of this presumed metabolite in all the appropriate bioassay systems.
Thus we have tvo distinct hypotheses. First, that aflatoxin B1 may be activated by a metabolic conversion to hemiacetal which binde to various key en~s and metabolically important liver cell structures. This we might call formation of the acute toxin. Second, that the toxin is activated to the hypothetical 2,3-oxide and because it is mutaganie it is also presumed to be the proximal carcinogen. Any 2, 3-oxide unreacted wi th DNA might be hydrated en~cally in the liver to fom the dihydrodiol of aflatoxin which would have Toxic residues. Little is known of the relative ratee of sterigmatocyetin metabolism by livers of different animal speciee, but clearly thoee metabolising it slowly are likely to accumulate this carcinogenic toxin in their tissues. By analogy with aflatoxin it is also possible that a 4-hydroxy compound is formed metabolically end i f so this would presumably be toxic as the 2,3-vinyl ether grouping is generally assumed to be the active centre of the sterigmatocystin molecule.
Metabolie activation. Liver preparations which form the hemiacetal of the aflatoxin in vitro fail to carry out the equivalent transformation when sterigmatocystin is used as substrate (Ref. 9) . Therefore this type of metabolic activation would seem to be unlikeli. However, ueing the bacterial mutagenicity test, Gar.ner end bis colleagues {Ref. 12 end 13 have ehown that the presumed 2,3-oxide is probably formed by liver microsomes {see Detoxification. The only metabolic reaction of ochratoxin A resulte in detoxification. Hydrolysis catalysed by carboxypeptidaee A breaks the amide bond {Ref. 18) with the fo:rmation of the naturally occurring aminoacid phenylalanine plus ochratoxin Q (Fig. 5) . The latter ieocoumarin carboxylic acid is very much lese toxic than the parent toxin ochratoxin A in all acute in vivo end in vitro test systems {e.g. Ref.
19) end thus the complete toxin molecule appears to be required to achieve i te toxic effect.
Toxic reeidues. Ite precise mode of action end the reaeons for its peculiar affinity for the proximal tubules of the kidney rema.in unknown but ochratoxin A binde strongly to protein end the affinity constant is.higher for this toxin than the dechloro-derivative ochratoxin B {Ref. 20). As a protein binding agent ochratoxin A clearly preeente a toxic reeidue problem. Pigs expoeed to this toxin in their diet accumulate ochratoxin A in kidney, liver end muscle (in decreasing order) end the experimental regression equations of Krogh and his colleaguee {Ref. 21) have been found by other experimenterB {Ref. 22) to provide a fairly good means of predicting levele of these toxic residuee.
TRICHOTHECENES
This group comprises over 30 toxins elaborated by Fusarium, Trichothecium, end Stachybot;ys spp. for example end none appears to be metabolically activated. Their necrogenic action on the skin demonstrates that at least in this particular mode of action this is the case. Therefore these mycotoxins will also be considered under two headings only.
Detoxification. Assuming that the epoxide group is the "active centre" of the typical trichothecene molecule it is obvious that modifications of acyl or eeter groups R1, R2, R3, end R4 {see Fig. 6 ) will only have modifying effects on toxicity. Thue there is evidence In the generalised structure of these texins given above R1, R2, R3 and ~ may be hydrogen, hydroxyl, esteritied hydroxyl, keto (R4 only), epoxide (replaces R4 and adjacent OH group), or a macrocyclic bridge may link: R1 and the adjacent CH~ group. The OH group adjacent to R4 is replaced by hydrogen in some toxin molecules.
R,
Ring rearrangement (Fig. 6 ) occurs under strongly acid conditions but our own unpublished experiments have shown that in the milder acidic conditions of the stomach this rearrangement is extremely unlikely.
Toxic residues. Nothing is lmown of in vitro stability or rates of metaboliam of this group of toxins in different animal species but i t has been shown that binding to sulphydryl groups of cysteine, glutathione and protein molecules occurs (Ref. 27) . This may prove to be an essential part of the mode of action of these toxins but equally it may denote a potential residue problem when domestic animals have been exposed to trichothecene contaminated feeds.
ZEARALENONE
Another Fusarium toxin, the toxicology of zearalenone has received much attention but rather little is lmown of its metabolism and mode of action.
Detoxification. No pathways have yet been defined but at least two of the possible metabolites of zearalenone contain hydroxyl groups and presumably conj~tes such as glucuronides could be formed by microsomal glucuronyl transferases (see Fig. 7 ).
Toxic residues. Again no information is available to identify animal species that metabolise zearalenone slowly but such a farm animal could possibly store toxic residues of the unchanged toxin with attendant health risks to the human consumer. Several metabolites of zearalenone are lmown to be formed by NAD/NADP-linked dehydrogenases present in the liver cell sap (Ref. 28) and these soluble enzymes probably convert the parent toxin into three oestrogenic compounds. If, as seems likely, reduction of the 8'-carbonyl group is essential for oestrogenic activity, perhaps this occurs at the site of action.
Zearalenol {or zeranol, Ralgro(R)) is a widely approved anabolic preparation used for fattening cattle from which it is obvious that residues of this compound present very much less of a publie health problem than diethylstilboestrol for example. Therefore it is probable that metabolites of zearalenone present only theoretical hazards as toxic residue~ possibly in adipose tissues of animals that metabolise this toxin slowly.
Activated form. This has been discussed above in relation to general metabolism of this toxin.
Oli5TROGENIC TOXINS AND PSEUDO-STEROIDS
Zearalenone and its reduction products are uterotropic like oestradiol 17 p and, although these toxin molecules are not steroids, their oestrogenic activity must depend upon steroidlike interaction with appropriate receptor sites. This may involve pairs of hydroxyl or potential hydroxyl groups. Thus, as shown in Fig. 8 And then, what of the stomach and gastrointestinal tract? The acid conditions themselves, the action of digestive enzymes, and the gut flora are factors that have simply not been given sufficient attention. In the case of ruminants and other herbivores, microbial biotransformations surely cannot be without importance. 
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